Quest Diagnostics Incorporated DGX

236.32 (0.27) (0.11%) as of 25 Sep
Market cap
$26.2B
P/E
24.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Quest Diagnostics Incorporated (DGX) P/E ratio

As of 25 September 2026, Quest Diagnostics Incorporated (DGX) trades at a P/E ratio of 24.8×. Over the past ten years it has ranged from 7.7× (June 2021) to 25.9× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 19.6× 0.89%
FY2024 19.4× 4.51%
FY2023 18.6× (4.00%)
FY2022 19.3× 77.28%
FY2021 10.9× (3.03%)
FY2020 11.2× (33.04%)
FY2019 16.8× 8.69%
FY2018 15.4× (12.05%)
FY2017 17.6× (13.16%)
FY2016 20.2× 39.91%

Quarterly

Period P/E ratio Change
Jun 2026 22.2× 3.95%
Mar 2026 21.4× 9.24%
Dec 2025 19.6× (11.31%)
Sep 2025 22.1× 4.01%
42 more quarters

Against its own ten years

Low 7.7× High 25.9×
Ten-year median 18.5×
Current reading's percentile 99

P/E ratio against peers

Company P/E ratio
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated 24.8×
LH Labcorp Holdings Inc. compare 25.4×
MTD Mettler-Toledo International, Inc. compare 33.9×
MEDP Medpace Holdings, Inc. compare 35.6×
IDXX IDEXX Laboratories, Inc. compare 36.2×
ILMN Illumina, Inc. compare 50.4×
RVTY Revvity Inc. compare 72.0×
WAT Waters Corporation compare 108×
Diagnostics & Research industry median 33.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on DGX